WASHINGTON, Oct 6 (Reuters) - Bristol-Myers Squibb (BMY.N: Quote, Profile, Research) has strengthened its warning about the risk of possible fatal bleeding linked to its blood thinner drug, Coumadin, adding a black box to its label, U.S. health officials said on Friday.
